Enjoy complimentary customisation on priority with our Enterprise License!
The hydrocephalus shunts market size is forecast to increase by USD 101.8 million, at a CAGR of 4.7% between 2023 and 2028.
Explore in-depth regional segment analysis with market size data - historical 2018-2022 and forecasts 2024-2028 - in the full report.
Request Free Sample
The market continues to evolve, driven by advancements in shunt technology and the growing need for effective management of hydrocephalus, a condition characterized by the abnormal accumulation of cerebrospinal fluid (CSF) in the brain ventricles. Hydrocephalus shunts are medical devices used to divert CSF from the ventricles to other parts of the body, alleviating pressure and preventing further damage to the brain. Shunt tube materials have seen significant developments, with the use of biocompatible materials gaining popularity due to their ability to minimize shunt infections. Infection treatment remains a critical area of focus, with research ongoing to develop new antimicrobial coatings and materials for shunt tubes.
ICP monitoring techniques have advanced, with continuous CSF pressure monitoring systems gaining traction. These systems enable real-time monitoring of intracranial pressure, allowing for timely intervention in case of shunt malfunctions or complications. Catheter migration detection and fluid dynamics shunts are other areas of active research, with the goal of improving shunt performance and reducing complications. Shunt malfunction diagnosis techniques have also evolved, with neurological assessments and CSF flow dynamics analysis playing a crucial role in identifying and addressing issues. Ventricular shunt occlusion and ventriculoatrial shunts are alternative shunt types used in specific cases, while obstructive hydrocephalus and subcutaneous shunt placement are areas of ongoing research.
Chronic shunt failure, shunt series resistance, shunt longevity factors, and drainage system integrity are all critical aspects of shunt design and performance that continue to be explored. Neurological recovery and head circumference changes are important outcomes that are monitored in hydrocephalus patients, with gravitational drainage effects and shunt complications being key considerations in shunt management. The ongoing dynamism of the market reflects the continuous efforts to improve shunt technology and address the complexities of managing hydrocephalus.
The hydrocephalus shunts industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
The hydrocephalus valves segment is estimated to witness significant growth during the forecast period.
Hydrocephalus, a chronic neurological condition, arises from the malfunction of the cerebrospinal fluid (CSF) drainage mechanism in the brain. The standard treatment approach involves a shunt system, which comprises two catheters and a one-way valve. This valve manages the amount, flow direction, and pressure of CSF exiting the brain's ventricles. As intracranial pressure increases, the valve opens, allowing excess fluid to drain to a downstream cavity. In 2022, approximately 80% of patients were diagnosed with communicating hydrocephalus, where the obstruction occurs in the subarachnoid space or at the arachnoid granulations. In contrast, 20% of cases involved obstructive hydrocephalus, where the blockage is within the ventricles or aqueduct.
Shunt systems consist of various components, including reservoirs, valves, and tubing. Reservoir refills may be necessary to maintain optimal CSF pressure. Surgical shunt removal and hydrocephalus shunt revision procedures are common interventions. Valve malfunctions may manifest through symptoms such as increased head circumference, neurological deficits, or altered mental status. Programmable valve settings allow for customized CSF drainage based on individual patient needs. Post-operative monitoring is crucial to ensure proper shunt function and neurological recovery. Peritoneal shunt placement and lumboperitoneal shunt procedures are alternative shunt placement methods. Shunt complications, such as infection, catheter migration, and valve malfunction, necessitate prompt diagnosis and treatment.
Infection treatment may involve shunt removal and antibiotics. ICP monitoring techniques and CSF pressure monitoring are essential for managing shunt function and patient care. Fluid dynamics shunts, such as ventriculoatrial and ventriculoperitoneal shunts, have distinct advantages and disadvantages. Ventriculoatrial shunts may be preferred for obstructive hydrocephalus, while ventriculoperitoneal shunts are often used for communicating hydrocephalus. Shunt tube materials, drainage system integrity, and shunt series resistance are critical factors influencing shunt longevity. Complication prevention strategies, such as maintaining proper catheter-tip location and minimizing gravitational drainage effects, are essential to optimize shunt performance and patient outcomes.
The Hydrocephalus valves segment was valued at USD 191.10 million in 2018 and showed a gradual increase during the forecast period.
North America is estimated to contribute 45% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
The market is driven by the large number of cases in North America, where hydrocephalus affects over 1 million people. This condition, characterized by the excess production or impaired resorption of cerebrospinal fluid (CSF) in the brain, necessitates surgical intervention using pressure-regulated shunts. The market's growth is fueled by the rising number of brain surgeries, mergers and acquisitions, and advanced product launches. Shunt procedures include reservoir refills, surgical removals, and revisions. Valve malfunctions may cause symptoms such as increased head size, seizures, or decreased alertness. Programmable valve settings offer customized pressure relief. Post-operative monitoring is crucial for neurological assessment and CSF pressure monitoring.
Peritoneal shunts and ventriculoatrial shunts are common types, with catheter-tip location critical for effective drainage. Shunt complications include infection, catheter migration, occlusion, and shunt series resistance. Infection treatment involves antibiotics and shunt removal. ICP monitoring techniques and CSF flow dynamics assessments aid in diagnosis. Longevity factors include shunt materials, drainage system integrity, and neurological recovery. Prevention strategies focus on minimizing complications and optimizing shunt function. Obstructive hydrocephalus, a common form, can be treated with lumboperitoneal shunts or fluid dynamics shunts. Subcutaneous shunt placement and chronic shunt failure are other considerations. Gravitational drainage effects and head circumference changes are important factors.
Intracranial pressure and neurological assessment are crucial for effective treatment.
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The market has seen significant growth due to the increasing incidence of hydrocephalus, a condition characterized by the accumulation of cerebrospinal fluid in the ventricles of the brain. Ventricular shunt system failure is a common complication, with causes including shunt infection, obstruction, disconnection, and valve malfunction. Minimally invasive shunt placement techniques, such as endoscopic third ventriculostomy, have emerged as alternatives to traditional open surgery, reducing the risk of complications. Long-term complications after shunt surgery include shunt infection, overdrainage, and underdrainage, which can lead to various neurological symptoms. Advanced imaging techniques, such as magnetic resonance imaging (MRI) and computed tomography (CT), play a crucial role in diagnosing shunt malfunction. Clinical presentation of shunt dysfunction varies widely, from subtle cognitive changes to severe neurological deficits. Factors affecting shunt longevity and function include patient age, shunt design, and the underlying cause of hydrocephalus. Optimal shunt valve settings for patients depend on individual clinical needs, and comparing different shunt materials' properties is essential in selecting the most appropriate shunt for each patient. Surgical approach to shunt revision procedures varies based on the cause of failure and the patient's clinical condition. Prevention strategies for shunt infection include meticulous surgical technique, appropriate use of antibiotics, and patient education on infection symptoms. Post-operative care guidelines for shunt patients include regular follow-up appointments, monitoring for signs of infection, and proper wound care. Managing shunt complications in pediatric patients requires a multidisciplinary approach, involving neurologists, neurosurgeons, and other healthcare professionals. The effectiveness of various shunt types for hydrocephalus varies, with valve type and size being critical factors. Shunt placement's impact on neurological recovery depends on the timing and appropriateness of the intervention. Patient-reported outcomes following shunt surgery provide valuable insights into the quality of life and functional outcomes for patients. Imaging diagnostics play a crucial role in shunt malfunction assessment, and various methods, such as MRI and CT, are used to evaluate shunt system performance. Different shunt types and their applications depend on the underlying cause of hydrocephalus and the patient's clinical condition. Neurological monitoring after shunt implantation is essential for the early detection and management of complications. Techniques for shunt reservoir refill for hydrocephalus shunts are essential for maintaining proper cerebrospinal fluid drainage. The market is expected to grow significantly due to the increasing incidence of hydrocephalus and the development of advanced shunt technologies.
The hydrocephalus shunts market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the hydrocephalus shunts market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, hydrocephalus shunts market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.
B.Braun SE - This research focuses on a global medical device company specializing in hydrocephalus shunts. Their product portfolio encompasses blue valve, Progav 2.0 valve, Gav 2.0 valve, Mininav valve, Shuntassistant 2.0 valve, shunt accessories, Dualswitch valve, and Prosa valve.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Dive into Technavio's robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Hydrocephalus Shunts Market insights. See full methodology.
Market Scope |
|
Report Coverage |
Details |
Page number |
160 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 4.7% |
Market growth 2024-2028 |
USD 101.8 million |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
4.5 |
Key countries |
US, Germany, Japan, UK, Canada, India, China, South Korea, France, and Italy |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
We can help! Our analysts can customize this hydrocephalus shunts market research report to meet your requirements.
1 Executive Summary
2 Technavio Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Product
9 Customer Landscape
10 Geographic Landscape
11 Drivers, Challenges, and Opportunity/Restraints
12 Competitive Landscape
13 Competitive Analysis
14 Appendix
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
Secondary sources
DATA ANALYSIS
Data Synthesis
Data Validation
REPORT WRITING
Qualitative
Quantitative
Get the report (PDF) sent to your email within minutes.
Complimentary full Excel data with your report purchase.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.